A new intravenous drug to treat Alzheimer's is in development, and IU is looking for volunteers 50-88 years of age with mild to moderate symptoms to participate in a clinical trial.
The drug, named bapineuzumab, is designed to attack and destroy the proteins believed to be responsible for the memory loss and confusion associated with Alzheimer's disease.
Volunteers will undergo 20 rounds of testing at the IU Medical Center in Indianapolis. A caregiver must accompany each participant.
For more information about this or related studies on Alzheimer's, contact Elva Van Hook at 317-278-8389 or toll-free 866-257-0195.